We have described suggestive linkage between microsatellite markers within the cytogenetic region 18q21-23 and SLE, a region where linkage with other autoimmune diseases has also been detected. The Bcl-2 gene located within this region, is a candidate gene because of its role in apoptosis, a physiological mechanism that could be deregulated in autoimmune disease. Furthermore, several studies have found abnormalities of Bcl-2 expression in SLE patients. We therefore sought to determine if the Bcl-2 gene is involved in SLE by studying members of a large cohort of Mexican SLE patients (n = 378) and 112 Swedish simplex families. Using a microsatellite marker and two single nucleotide polymorphisms located within the gene, we were unable to detect association between Bcl-2 and SLE in either population. We also tested whether combinations of alleles of the Bcl-2 and IL-10.G microsatellites would increase the risk for SLE. Our results do not support such hypothesis. Our findings suggest that linkage between SLE and the 18q21-23 region is due to a gene other than Bcl-2. Genes and Immunity (2000) 1, 380-385.
Introduction
Previous studies have shown that the Bcl-2 molecule is important in the physiological regulation of apoptosis in the lymphoid system. [1] [2] [3] One mode of action that has been proposed is that Bcl-2 acts through increasing the longevity of antibody-producing B cells. This has led to the suggestion that alterations in Bcl-2 might be involved in the pathogenesis of systemic lupus erythematosus (SLE) by allowing autoreactive B cells to persist in the periphery. 4 Transgenic animals overexpressing Bcl-2 develop, in a particular genetic background, an immune complex disease resembling lupus glomerulonephritis. 4 Furthermore, increased expression of Bcl-2 in SLE patients with active disease has been described, [5] [6] [7] although this is somewhat controversial.
Recently, analysis of a microsatellite polymorphism in Bcl-2 suggested an association with SLE in MexicanAmerican patients. 8 In addition, we and others found evidence suggestive of linkage to the chromosome 18q21-23 region, where the Bcl-2 gene is located (18q21.3, www.gdb.org). [9] [10] [11] [12] To confirm the proposed association with Bcl-2, we have now performed the largest association study in Mexican SLE patients (n = 378) and ethnically matched controls to date for this gene. In addition, we analyzed 112 simplex families from a different population, the Swedish. The two cohorts were analyzed for two single nucleotide polymorphisms (SNPs) and a microsatellite, located within the Bcl-2 gene. Our results do not support an association between Bcl-2 and SLE and Table 1 shows the allele frequencies of the Bcl-2 microsatellite observed in our cohort of 338 Mexican Mestizo controls from the Mexico City area. In addition, we have included the allele frequencies for Mexican-Americans described by Mehrian et al, 8 for comparison and for the 155 non-affected parents of the Swedish SLE patients. The allele frequencies are very similar between Mexicans and Mexican-American controls, but differ significantly between those and the Swedish population with respect to alleles 191 and 195 (P = 0.0008 and P = 0.003, respectively). All genotype frequencies were in HardyWeinberg equilibrium.
Results
We then compared allele frequencies in relation to the SLE patients. The association analysis in Mexicans was performed by comparison of allele frequencies between patients and controls. As also shown in Table 1 , heterogeneity was observed in the Mexican Mestizo population when comparing allele 193 between patients and controls (P = 0.08 after Bonferroni correction). The same allele had shown an association with SLE in the study of Mehrian et al. 8 However, contrary to their results we observed that the frequency of this allele is lower instead of greater in patients with SLE. The analysis of the Swedish simplex families was performed determining the transmission of alleles from the parents to the SLE patient using the haplotype relative risk test (see Materials and methods). Even in the Swedish population the frequency of the 193 allele has a tendency to be lower among the patients. A corrected P value of P = 0.016 was obtained for the Bcl-2 microsatellite when using the HRR-LTR test (1 df), but not for the HRR-2xn test when individual alleles were analyzed (Table 2) .
In order to base our results on more than one polymorphism, we performed a search for SNPs within the Bcl-2 gene. Using the expressed sequence tag databases we Difference between Mexican controls and Mexican SLE patients: P Ͻ 0.01 before Bonferroni; P = 0.08 after Bonferroni correction (7 alleles −1). b Non-T, alleles not transmitted from parents to their SLE offspring; T, transmitted alleles from parents to the SLE offspring. The overall P values using the HRR-LTR and HRR2xn tests, respectively were: P = 0.016 (1 df), P = 0.15 (7 df). The boxed mRNA transcript is composed of two exons separate by a unique intron of more than 50kb determined by restriction enzyme mapping. 36 The black box indicates the coding sequence. The (CA)n microsatelite is at 540-bp upstream of the putative transcription start site (Accession number M14745). The SNP-52 is at 52 bp of the transcription start site and causes a silent mutation in the coding sequence. 30 could identify two SNPs, one of which is described here for the first time. Mexican patients and controls as well as the Swedish simplex families were genotyped using dynamic allele-specific hybridization (DASH) (see Materials and methods). The positions of the polymorphisms within the Bcl-2 gene are schematically depicted in Figure 1 .
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The SNP genotype frequencies in Mexican patients and controls are shown in Table 3 . No significant differences were observed for any of the SNP alleles (data not shown) or genotypes (Table 3) analyzed between Mexican SLE patients and controls. Analysis of the Swedish simplex families for both SNP polymorphisms was per- formed using HRR-LTR and HRR-2xn tests. No significant association was observed for any of the polymorphisms analyzed (Table 4) . Haplotypes were constructed for the Swedish simplex families. By doing this the information content of the polymorphisms (PIC value) was increased to 0.77. Two haplotypes were preferentially found containing, as expected, the most frequent allele of the microsatellite of 195 basepairs: 195-52A-1955G (37%) and 195-52G-1955G (32%). The possible association of any haplotype with SLE was analyzed in the simplex families using the HRR tests. The frequency of haplotypes transmitted to the patients did not deviate significantly as compared to the non-transmitted haplotypes (P = 0.24 (1 df) for the HRR-LTR test and P = 0.10 (11 df) for the HRR-2xn test.
We finally analyzed the possible interaction between Bcl-2 microsatellite alleles and alleles of the IL10.G microsatellite, as described by Mehrian et al. 8 We had previously performed an analysis of the IL10.G microsatellite in Mexican patients with SLE. 9 A total of 235 Mexican patients and 248 Mexican controls had information on both genes microsatellites. No allele combination increased the risk to develop SLE as compared to controls, and thus we cannot confirm that a synergistic interaction exists between IL-10 and Bcl-2 in this cohort of Mexican patients with SLE (data not shown).
Discussion
Apoptosis is one of the physiological mechanisms through which self tolerance is maintained in the immune system. Therefore, its de-regulation may lead to autoimmune diseases such as SLE. The pathogenic mechanisms by which this may happen are unknown. In SLE, various possibilities have been proposed. Defects in apoptosis may be involved in the increased survival of autoreactive B cells in the periphery which may become precursors of pathogenic autoantibodies. [4] [5] [6] [7] On the other hand, uncontrolled apoptosis may lead to the release of autoantigens with the subsequent stimulation of autoantibody production. 13, 14 Numerous studies have shown increased apoptosis of mononuclear cells and neutrophils from SLE patients, 15, 16 and the release of lupus-related autoantigens when apoptosis is induced in vivo 17 and in vitro. 18 It has also been proposed that apoptotic bodies may not be properly cleared in SLE patients. 19 Interestingly, apoptotic 'blebs' are formed following UVB irradiation in keratinocytes. The clearance of such apoptotic bodies appears to occur through a C1q-dependent pathway suggesting that C1q complement deficiency and de-regulated apoptosis could be involved in the pathogenesis of SLE through a common mechanism. 20 In addition, some lupus autoantibodies may cause apoptosis by penetrating into cells. 21, 22 The pathogenic mechanisms leading to defective apoptosis are unknown. Bcl-2 is an anti-apoptotic molecule. Transgenic animals in which increased B cell survival has been induced through the over-expression of Bcl-2 develop, under a certain genetic background, lupus autoantibodies and glomerulonephritis. 4 Whether Bcl-2 is over-expressed or not in lupus patients is a matter of controversy, and possibly related to the difficulty in defining the status of activity or inactivity of the lupus patients being studied. The use of medication or the possibility that Bcl-2 may be over-expressed in certain cellular subsets and not in others may contribute to the controversy in the results. [5] [6] [7] 23, 24 The role of Bcl-2 in SLE susceptibility was recently suggested by Mehrian et al, 8 when they showed that alleles of a microsatellite located in the promoter region of the Bcl-2 gene were associated with this disease. We have analyzed the same microsatellite as Mehrian et al, and similarly we found differences in the frequencies of allele 193 between patients and controls. However, and contrary to their results the 193 allele had a lower frequency in lupus patients. This difference was not significant after Bonferroni correction for multiple testing. A similar observation was found for the Swedish patients. We did observe an increase of allele 195 in Swedish patients, but this was not significant. We analyzed whether an interaction exists between microsatellite alleles of the I-L10 and Bcl-2 genes, as previously described, however we do not confirm those results. Our previous work had shown no association between the IL-10 microsatellite and SLE in Mexicans. 9 There is however the possibility that other polymorphisms within the IL-10 gene may be of more relevance and that indeed, such interaction may exist. This hypothesis would have to be tested.
The genes behind the development of SLE may be varied and differ from one population to another. In addition, there may be allelic heterogeneity. For this reason we have studied the importance of the Bcl-2 gene in patients from two distinct populations, one (Mexican Mestizos) akin to that used by Mehrian et al 8 (MexicanAmericans), and the other rather dissimilar (Swedes). Accordingly, we did not observe allele frequency differences between our Mexican Mestizos and the MexicanAmerican control cohort of Mehrian et al, while we did observe significant differences in the allele frequency distribution between Swedes and Mexicans. This underscores the importance of taking population genetics into consideration when studying the genetics of SLE. Thus, association analysis of both groups, independently, does not support the role of Bcl-2 in SLE susceptibility.
The causal mutation/variation may be younger or older than the polymorphism used in the analysis and thus, the microsatellite might not be in linkage disequilibrium with such a variation. Taking this possibility into consideration, SNPs were searched and two were identified, one of which is reported here for the first time. The results obtained with the SNPs support our findings with the microsatellite of no association. We finally constructed haplotypes from the Swedish family data and did not find any significant differences in transmission.
Our results do not support the association of Bcl-2 with 383 SLE because the allele frequency of allele 193, contrary to its previously described increase, was reduced in SLE patients (and this reduction was not significant), none of the SNP alleles show a significant difference in any of the populations studied, and the increase of the 195 allele in the Swedish population is not significant. Interestingly, linkage to the 18q21-23 region, where Bcl-2 is mapped, has been observed in family studies performed for rheumatoid arthritis 25 and insulin-dependent diabetes mellitus, 26 as well as in SLE, [10] [11] [12] suggesting that a common autoimmunity gene may be found somewhere in this region. We conclude, however that such a gene is not likely to be Bcl-2.
Materials and methods

Patients and families
The 378 Mexican patients were all Mestizo subjects from the Mexico City area. In addition, 338 ethnically matched Mexican controls were used. The Swedish simplex families were as follows: 112 Swedish patients mainly from mid and southern Sweden whose grandparents were born in Sweden and with one or both parents alive. A total of 154 parents were available. All patients fulfilled the 1982 classification criteria of the ACR for SLE. 27 None of the patients had a family history of SLE. All individuals were previously informed of the aim of the project. The Swedish patients have given written consent to contact their relatives who were contacted by telephone and informed of the aim of the project.
Genotyping of the Bcl-2 microsatellite
The dinucleotide repeat located in the promoter region of the Bcl-2 gene and which has been previously described, 8 was genotyped. Its location is shown in Figure 1 . Genotyping was performed using a semiautomated fluorescent-based method. The primers used for the Bcl-2 dinucleotide polymorphism were those described by Mehrian et al. 8 The primer sequences used were: 5Ј CGT GTA CAC ACT CTC ATA CAC GGC T 3Ј and 5Ј GGG AGG GTG CGC CAT GAA AA 3Ј. The fluorescent dye 6-FAM was conjugated to the downstream primer. A 5Јgtttctt3Ј tail was attached to the upstream primer to facilitate genotyping. 28 Such a tail does not alter PCR conditions or genotyping results. 28 The polymerase chain reaction (PCR) was run under the following conditions: 25 ng of DNA were used in a reaction mix containing 200 M of each dNTP, 2.5 pmole of each primer, 0.5 U TaqGold (Perkin-Elmer, ABI, Foster City, CA, USA) and reaction buffer (final concentration of 50 mm KCl, 10 mm TRIS-HCl at pH 8.3, 1.5 mm MgCl 2 ). The total reaction volume was 15 l. The PCR was performed in a 9600 thermal cycler (Perkin-Elmer, ABI). After initial denaturation and activation of the enzyme TaqGold for 10 min at 95°C the samples were run 30 cycles of 30 sec at 95°C, 30 sec at 57°C and 30 sec at 72°C. This was followed by a final extension step of 7 min at 72°C. The PCR product was diluted 1:10 before 1 l was mixed with 1.5 l formamide-EDTA and 0.7 l of the TAMRA-conjugated size standard GS350 (Applied Biosystems Inc).
Fragment analysis of the Bcl-2 gene polymorphism was done on an ABI 373 machine using the Genescan software version 1.0. Allele calling was performed using the Genotyper software version 2.0. Inconsistencies in the simplex families were analyzed using GAS version 2.0 (Alan Young, Oxford University, 1993-1995) on a SunSparc Unix system.
Search for single nucleotide polymorphisms (SNPs) for Bcl-2
Single nucleotide polymorphisms in the Bcl-2 gene were searched for in the literature as well as in silico using the human Bcl-2 mRNA sequence as reference (Accession number M14745). The sequence was run against human expressed sequence tags (ESTs) stored in the HGMP database (http://www.hgmp.ac.uk). Fifteen putative SNPs were detected and evaluated by DASH as described below 29 using a panel of 10 unrelated individuals from the Mexican Mestizo population and 10 from the Swedish population. Two of the potential SNPs were confirmed in this population, one corresponding to the transition G to A at position 52 of the reference sequence and which has been previously described 30 and a new G to A transition at position 1955, detected by ESTs data assembly. The position 52 polymorphism is in the coding region but does not result in an amino acid substitution. The one at position 1955 is in the 3ЈUTR of the Bcl-2 gene. Their position with respect to the Bcl-2 microsatellite is shown in Figure 1 .
Genotyping of Bcl-2 SNP markers
Genotyping of the SNPs was performed using the DASH methodology with minor modifications. 29 The PCR reaction was optimized for each primer pair. The downstream primers were conjugated with biotin. The primers were as follows: SNP52 forward 5ЈGAA ATA TGG CGC ACG CTG GGA3Ј and biotinylated 5ЈCAC TAT CTC CCG GTT ATC GTA3Ј; SNP1955 forward 5ЈTTC ACG TGG AGC ATG GGA GC3Ј and biotinylated 5ЈTCC CTC TAC AGT GAT ACA TGT C3Ј. After amplification, a volume of 10 l of the PCR reaction was bound overnight to streptavidin-coated microtitre plates (Hybaid Limited, Middlesex, UK). After washing away the non-biotinylated strand with alkali, hybridization was done separately for each of the allele-specific probes (match and mismatch probes), at low temperature. The allele specific probes for SNP52 were 5ЈGGAGAACg/aGGGTACG3Ј and for SNP1955 5ЈGAGCCACg/aACCCTTC3Ј. The sample was then steadily heated while fluorescence was monitored using a Perkin-Elmer 7700 TaqMan machine (Applied Biosystems Inc). The amount of fluorescence is proportional to the amount of hybridized double-stranded DNA, and the difference in hybridization between the match and mismatch probes can be analyzed using the negative first derivatives as genotypes for each individual. The genotypes were determined visually.
Association analysis
Allele frequencies in the Mexican patients and controls were determined by manual counting. Statistical analysis was performed using contingency tables and a 2 test on version 4.5 of STATVIEW (Abacus Concepts, Berkeley, CA, USA). The Bonferroni correction was used to correct the P values for multiple testing. For the Swedish simplex families, two types of analysis were performed: a likelihood-based haplotype relative risk test (HRR-LTR) and a applied in the ANALYZE software by Terwilliger.
30,31
The marker alleles transmitted from both heterozygous and homozygous parents to affected offspring are used as the case sample and the non-transmitted alleles are treated as an independent genetically-matched control sample. The likelihood was then computed following the method of Terwilliger 32 as a function of , the proportion of association observed in the sample.
Haplotypes were constructed by using the LINK-MEND and SIMWALK algorithms [33] [34] [35] and analyzed using ANALYZE as described above with HRR-LTR and HRR-2xn tests. Results are expressed as P values. The frequency of transmitted vs non-transmitted alleles were calculated manually. Analysis of Il-10 and Bcl-2 allele combinations was performed with 2×2 contingency tables. A total of 50 combinations were analyzed and the interaction was estimated by calculating the odds ratio between patients and controls.
